TY - JOUR
T1 - Interval between onset of symptoms and diagnosis of medulloblastoma in children
T2 - Distribution and determinants in a population-based study
AU - Brasme, Jean François
AU - Chalumeau, Martin
AU - Doz, François
AU - Lacour, Brigitte
AU - Valteau-Couanet, Dominique
AU - Gaillard, Stephan
AU - Delalande, Olivier
AU - Aghakhani, Nozar
AU - Sainte-Rose, Christian
AU - Puget, Stéphanie
AU - Grill, Jacques
PY - 2012/1/1
Y1 - 2012/1/1
N2 - Hospital-based studies have reported long delays in the diagnosis of paediatric brain tumours. Our objective was to describe the duration between onset of symptoms and diagnosis of medulloblastoma in children and study their clinical determinants in a population-based study. This retrospective cohort study included all paediatric medulloblastoma from a region of France from 1990 to 2005. The median interval from symptom onset until diagnosis for these 166 patients was 65 days and did not decrease during the study period. The most frequent manifestations were: vomiting (88%), headaches (79%), psychomotor regression (60% of children under 3 years), psychological symptoms (27%), strabismus (26%), and asthenia (25%). For one third of the children under 3 years, the diagnosis was made only after life-threatening signs of intracranial hypertension appeared. The prediagnosis interval was significantly longer (median 91 vs. 60 days, p = 0.001) in children with psychological symptoms (27%). Causes for intervals that exceeded the median (65 days) included inconsistent (25%) or late (36%) combination of headaches and vomiting, a period of spontaneous symptom remission (14%-20%), no (24%) or late (57%) neurological signs, psychological symptoms (35%), and a normal neurological examination (27%). Time to medulloblastoma diagnosis in children remains fairly long, despite advances in imaging. Primary-care physicians must be suspicious not only of suggestive neurological signs, but also of non-specific symptoms that persist or are multiple. A meticulous neurological examination and cerebral imaging for such patients might facilitate earlier diagnosis.
AB - Hospital-based studies have reported long delays in the diagnosis of paediatric brain tumours. Our objective was to describe the duration between onset of symptoms and diagnosis of medulloblastoma in children and study their clinical determinants in a population-based study. This retrospective cohort study included all paediatric medulloblastoma from a region of France from 1990 to 2005. The median interval from symptom onset until diagnosis for these 166 patients was 65 days and did not decrease during the study period. The most frequent manifestations were: vomiting (88%), headaches (79%), psychomotor regression (60% of children under 3 years), psychological symptoms (27%), strabismus (26%), and asthenia (25%). For one third of the children under 3 years, the diagnosis was made only after life-threatening signs of intracranial hypertension appeared. The prediagnosis interval was significantly longer (median 91 vs. 60 days, p = 0.001) in children with psychological symptoms (27%). Causes for intervals that exceeded the median (65 days) included inconsistent (25%) or late (36%) combination of headaches and vomiting, a period of spontaneous symptom remission (14%-20%), no (24%) or late (57%) neurological signs, psychological symptoms (35%), and a normal neurological examination (27%). Time to medulloblastoma diagnosis in children remains fairly long, despite advances in imaging. Primary-care physicians must be suspicious not only of suggestive neurological signs, but also of non-specific symptoms that persist or are multiple. A meticulous neurological examination and cerebral imaging for such patients might facilitate earlier diagnosis.
KW - Brain tumours
KW - Delayed diagnosis
KW - Early diagnosis
KW - Epidemiology
KW - Medulloblastoma
KW - Signs and symptoms
UR - http://www.scopus.com/inward/record.url?scp=84857051497&partnerID=8YFLogxK
U2 - 10.1007/s00431-011-1480-z
DO - 10.1007/s00431-011-1480-z
M3 - Article
C2 - 21537925
AN - SCOPUS:84857051497
SN - 0340-6199
VL - 171
SP - 25
EP - 32
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
IS - 1
ER -